Dr. Pouya Alexander Ameli, MD, MS

Dr. Ameli practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Ameli's NPI, 1760801815, was assigned on April 15, 2014. Dr. Ameli graduated from University of Central Florida College of Medicine in 2014. Dr. Ameli holds Florida license ME145264.

Dr. Ameli's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Ameli's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Dr. Ameli is also affiliated with UF Health Spanish Plaines Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Ameli to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ameli practices, 3 sites in all. Vendor and product names are available with a free account.

Neurocritical care is Dr. Ameli's primary specialty in the NPI Registry, under taxonomy code 2084A2900X. Dr. Ameli is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Ameli's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists cerebrovascular disease, epilepsy and neuropathy among the conditions Dr. Ameli treats.

CMS data shows 290 Medicare services from Dr. Ameli across 2 procedure codes in 2024, for 124 Medicare patients. Medicare paid $45,341 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Ameli in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ameli's median patient age at 73, with 39% women.

In 2018, Dr. Ameli wrote 51 Medicare Part D claims. They cover 3 drugs, with $662 in total drug cost. In 2017, CMS named 50 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Ameli for performance year 2024, reported through an alternative payment model (APM). Dr. Ameli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Ameli, published from 2013 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Seizures. Dr. Ameli has published most often in Crit Care Explor. Dr. Ameli's most frequent co-authors are Carolina Barbosa Maciel, MD, Katharina Maria Busl, MD and Marc-Alain Babi, MD.

CMS Open Payments shows 5 general payments to Dr. Ameli from 3 drug and device companies from 2021 to 2022. Food and beverage make up the largest share, 98% of the total. Marinus Pharmaceuticals, Inc. paid the most, $198.

Dr. Ameli graduated from University of Central Florida College of Medicine in 2014. Dr. Ameli is a member of AAN, Neurocritical Care Society and SCCM.

Dr. Ameli is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.